Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.66% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.55% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Communication Services | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Preformed Line Products
PLPC
$2.29B
| $4.27M | ﹤0.01% |
65,716
-387
| -0.6% | -$27.3K |
|
|
ZOM
3002
DELISTED
Zomedica Corp.
ZOM
| $4.26M | ﹤0.01% |
8,147,348
+265,719
| +3% | +$157K |
|
3003
Vor Biopharma
VOR
$1.32B
| $4.26M | ﹤0.01% |
13,597
+3,861
| +40% | +$1.15M |
|
3004
Puma Biotechnology
PBYI
$450M
| $4.26M | ﹤0.01% |
607,151
-13,975
| -2% | -$105K |
|
|
SDC
3005
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $4.25M | ﹤0.01% |
799,649
-52,606
| -6% | -$327K |
|
3006
AST SpaceMobile
ASTS
$21.4B
| $4.24M | ﹤0.01% |
392,164
+5,120
| +1% | +$57.4K |
|
|
AGS
3007
DELISTED
PlayAGS
AGS
| $4.23M | ﹤0.01% |
537,404
-39,400
| -7% | -$313K |
|
|
KNBE
3008
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $4.23M | ﹤0.01% |
192,801
+83,023
| +76% | +$2.07M |
|
3009
Orrstown Financial Services
ORRF
$850M
| $4.22M | ﹤0.01% |
180,385
+1,162
| +0.6% | +$27K |
|
|
LENZ
3010
LENZ Therapeutics
LENZ
$145M
| $4.22M | ﹤0.01% |
+36,768
| New | +$5.45M |
|
|
SEI
3011
Solaris Energy Infrastructure
SEI
$3.94B
| $4.22M | ﹤0.01% |
505,812
-12,992
| -3% | -$105K |
|
|
TIGR
3012
UP Fintech Holding
TIGR
$833M
| $4.22M | ﹤0.01% |
400,506
+40,673
| +11% | +$638K |
|
3013
AquaBounty Technologies
AQB
$7.72M
| $4.21M | ﹤0.01% |
51,664
+4,363
| +9% | +$409K |
|
|
PSTL
3014
Postal Realty Trust
PSTL
$701M
| $4.2M | ﹤0.01% |
225,426
+4,059
| +2% | +$77.8K |
|
3015
Lufax Holding
LU
$1.31B
| $4.19M | ﹤0.01% |
151,596
+17,137
| +13% | +$569K |
|
3016
Methanex
MEOH
$4.17B
| $4.18M | ﹤0.01% |
90,743
+4,840
| +6% | +$175K |
|
|
PLXP
3017
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $4.17M | ﹤0.01% |
216,162
+15,321
| +8% | +$268K |
|
3018
Lifecore Biomedical
LFCR
$181M
| $4.16M | ﹤0.01% |
450,794
-288
| -0.1% | -$3.13K |
|
|
SEEL
3019
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $4.15M | ﹤0.01% |
448
+94
| +27% | +$808K |
|
3020
Luxfer Holdings
LXFR
$457M
| $4.15M | ﹤0.01% |
211,254
-6,047
| -3% | -$125K |
|
3021
National CineMedia
NCMI
$252M
| $4.14M | ﹤0.01% |
116,454
+15,236
| +15% | +$495K |
|
|
ESPR
3022
DELISTED
Esperion Therapeutics
ESPR
| $4.12M | ﹤0.01% |
341,871
-109,094
| -24% | -$1.59M |
|
|
IMDX
3023
Insight Molecular Diagnostics
IMDX
$147M
| $4.12M | ﹤0.01% |
57,842
-3,032
| -5% | -$279K |
|
3024
PubMatic
PUBM
$783M
| $4.11M | ﹤0.01% |
155,976
+81,071
| +108% | +$2.43M |
|
3025
Tecnoglass Holdings Inc.
TGLS
$1.86B
| $4.11M | ﹤0.01% |
189,102
-274
| -0.1% | -$5.77K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.